WEBINAR VIDEO | What do the CJEU’s decisions on parallel trade of medicines mean for your company?

WEBINAR VIDEO | What do the CJEU’s decisions on parallel trade of medicines mean for your company?
December 21, 2022

At this additional Christmas edition, the IP specialists in our Life Sciences team discuss the CJEU’s latest decisions on the parallel trade of medicines, and what these decisions mean in practice for your company.

On 17 November 2022, the CJEU delivered essentially two decisions on the parallel trade of medicines. The first concerned the rebranding of generic medicines to the branded reference medicine (in joined cases C-253/20 and C-254/20), and about which we published a blog on 24 November 2022. The second addressed the impact of anti-tampering devices on the possibility, and objective necessity, to rebox (in C-224/20 and C-147/20), and about which we published a blog on 2 December 2022.

Contact

  • Kirian Claeyé

    Partner

Recommended articles

February 14, 2024

The authors of Ravel’s Boléro: Towards a revival of copyright in the Basque composer’s masterpiece?

A blog about Maurice Ravel on Valentine's Day? No doubt we'll be talking about Daphnis et Chloé or Don Quichotte à Dulcinée? Well, no. It's obviously the Boléro that this post is about. The chef-d’oeuvre of the French composer is at the centre of a high-profile trial, the first hearing of which is scheduled to take place today before the Tribunal de Grande Instance in Nanterre. At issue is the possible reinstatement of this essential score in the private domain.

Read on
February 08, 2024

WEBINAR VIDEO | A must-use tool for all businesses, to be handled with knowledge and caution to avoid any damage

During this webinar, Sophie Lens and Julie Peeters identify some of the issues associated with AI use within a company (such as with data protection, intellectual property and/or trade secrets) and look at the solutions that can be used in practice to deal with them and enable your company to reap AI’s full benefits while reducing the related risks.

Read on
January 31, 2024

Changes in the law on marketing of veterinary medicines: what you need to know

Belgium is welcoming a significant development in the field of veterinary medicine law. The Act of 11 July 2023 containing various provisions on health, which entered into force on 8 September 2023, introduces changes across a wide spectrum of healthcare domains, which are encompassed in approximately 20 chapters.

Read on